At a glance
ClinicalIndex Comparison RecordN/ACompleted· 64 enrolled
Drug / intervention
posaconazoledrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Inflammation on Pharmacokinetics of Posaconazole
In Brief
An observational study evaluating posaconazole for Mycoses. Completed, enrolled 64 participants across 1 site.
Detailed Summary
Posaconazole plasma concentration and inflammatory markers will be determined in all samples available from routine analysis.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMycoses
CountriesNetherlands
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJul 2015
Enrollment StartAug 2015
Primary CompletionJun 2017
Study CompletionAug 2017
TodayJul 2026
First PostedJul 9, 2015
Enrollment StartAug 13, 2015
Primary CompletionJun 1, 2017
Study CompletionAug 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 11.0 years ago
Interventions
posaconazoledrug
collection plasma samples for measuring posaconazole drug concentration